Annual FCF:
-$73.24M-$11.82M(-19.24%)Summary
- As of today, ELVN annual free cash flow is -$73.24 million, with the most recent change of -$11.82 million (-19.24%) on December 31, 2024.
- During the last 3 years, ELVN annual free cash flow has fallen by -$53.91 million (-278.97%).
- ELVN annual free cash flow is now -734.41% below its all-time high of -$8.78 million, reached on December 1, 2018.
Performance
ELVN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$13.28M+$3.92M(+22.78%)Summary
- As of today, ELVN quarterly free cash flow is -$13.28 million, with the most recent change of +$3.92 million (+22.78%) on September 30, 2025.
- Over the past year, ELVN quarterly free cash flow has dropped by -$1.06 million (-8.70%).
- ELVN quarterly free cash flow is now -105.51% below its all-time high of -$6.46 million, reached on September 30, 2022.
Performance
ELVN Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$71.82M-$1.06M(-1.50%)Summary
- As of today, ELVN TTM free cash flow is -$71.82 million, with the most recent change of -$1.06 million (-1.50%) on September 30, 2025.
- Over the past year, ELVN TTM free cash flow has dropped by -$3.29 million (-4.81%).
- ELVN TTM free cash flow is now -652.71% below its all-time high of -$9.54 million, reached on March 1, 2020.
Performance
ELVN TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ELVN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -19.2% | -8.7% | -4.8% |
| 3Y3 Years | -279.0% | -105.5% | -94.5% |
| 5Y5 Years | -232.6% | -28.3% | -146.4% |
ELVN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -279.0% | at low | -105.5% | +45.0% | -99.9% | +2.9% |
| 5Y | 5-Year | -279.0% | at low | -105.5% | +45.0% | -146.4% | +2.9% |
| All-Time | All-Time | -734.4% | at low | -105.5% | +45.0% | -652.7% | +2.9% |
ELVN Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$13.28M(+22.8%) | -$71.82M(-1.5%) |
| Jun 2025 | - | -$17.20M(+28.8%) | -$70.76M(+4.4%) |
| Mar 2025 | - | -$24.15M(-40.4%) | -$74.00M(-1.0%) |
| Dec 2024 | -$73.24M(-19.2%) | -$17.20M(-40.8%) | -$73.24M(-6.9%) |
| Sep 2024 | - | -$12.21M(+40.2%) | -$68.53M(+5.1%) |
| Jun 2024 | - | -$20.44M(+12.6%) | -$72.22M(-13.0%) |
| Mar 2024 | - | -$23.38M(-87.1%) | -$63.92M(-4.1%) |
| Dec 2023 | -$61.42M(-70.9%) | -$12.50M(+21.5%) | -$61.42M(-1.7%) |
| Sep 2023 | - | -$15.91M(-31.1%) | -$60.41M(-18.5%) |
| Jun 2023 | - | -$12.14M(+41.9%) | -$50.96M(-10.2%) |
| Mar 2023 | - | -$20.88M(-81.7%) | -$46.25M(-28.7%) |
| Dec 2022 | -$35.93M | -$11.49M(-77.8%) | -$35.93M(+2.7%) |
| Sep 2022 | - | -$6.46M(+13.0%) | -$36.93M(+10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$7.43M(+29.6%) | -$41.37M(+6.6%) |
| Mar 2022 | - | -$10.55M(+15.5%) | -$44.31M(+5.3%) |
| Dec 2021 | -$19.32M(+48.4%) | - | - |
| Dec 2021 | - | -$12.48M(-14.5%) | -$46.78M(-9.9%) |
| Sep 2021 | - | -$10.90M(-5.2%) | -$42.56M(-1.3%) |
| Jun 2021 | - | -$10.37M(+20.5%) | -$42.01M(-2.7%) |
| Mar 2021 | - | -$13.03M(-57.7%) | -$40.91M(-9.3%) |
| Dec 2020 | -$37.42M(-69.9%) | -$8.27M(+20.1%) | -$37.42M(-28.4%) |
| Sep 2020 | - | -$10.35M(-11.7%) | -$29.15M(-55.0%) |
| Jun 2020 | - | -$9.26M(+2.9%) | -$18.80M(-97.1%) |
| Mar 2020 | - | -$9.54M | -$9.54M |
| Dec 2019 | -$22.02M(-150.8%) | - | - |
| Dec 2018 | -$8.78M(+0.1%) | - | - |
| Dec 2017 | -$8.79M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Enliven Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Enliven Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of ELVN is -$73.24M
What is the all-time high annual free cash flow for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual free cash flow is -$8.78M
What is Enliven Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, ELVN annual free cash flow has changed by -$11.82M (-19.24%)
What is Enliven Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of ELVN is -$13.28M
What is the all-time high quarterly free cash flow for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly free cash flow is -$6.46M
What is Enliven Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, ELVN quarterly free cash flow has changed by -$1.06M (-8.70%)
What is Enliven Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of ELVN is -$71.82M
What is the all-time high TTM free cash flow for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM free cash flow is -$9.54M
What is Enliven Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, ELVN TTM free cash flow has changed by -$3.29M (-4.81%)